OPMEDIC GROUP Inc.
TSX : OMG

OPMEDIC GROUP Inc.

March 20, 2006 23:59 ET

OPMEDIC GROUP Inc. Announces the Appointment of Jean Larivée as New Director

MONTREAL, March 20 /CNW Telbec/ -

OPMEDIC GROUP Inc. ("OPMEDIC GROUP")(TSX:"OMG"),
a healthcare-related services company providing facilities and
services to patients and surgeons, is pleased to announce the appointment of
Jean Larivée as director of the Company, bringing to OPMEDIC GROUP board
experience from various public companies listed on the TSX. Simultaneously
with the appointment of Jean Larivée, Mr. Jacques Lemieux resigned as director
of the Company and has been appointed as Corporate Secretary, replacing
Dr. Marc Villeneuve, who remains director but decided to concentrate his
activities on the OPMEDIC GROUP's operations and ongoing projects.

The Board welcomes Mr. Larivée and congratulates Mr. Jacques Lemieux for
his new appointment.


About OPMEDIC GROUP


OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".


This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offerting would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

The Content of this press release has not been approved by nor submitted
to the TSX which assumes no liability therefore.

Contact Information